Redmile Group’s Achilles Therapeutics plc American Depositary Shares ACHL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,608,089
| Closed | -$1.83M | – | 64 |
|
|
2024
Q4 | $1.83M | Hold |
1,608,089
| – | – | 0.13% | 56 |
|
|
2024
Q3 | $1.64M | Hold |
1,608,089
| – | – | 0.1% | 59 |
|
|
2024
Q2 | $1.31M | Hold |
1,608,089
| – | – | 0.08% | 59 |
|
|
2024
Q1 | $2.01M | Hold |
1,608,089
| – | – | 0.07% | 72 |
|
|
2023
Q4 | $1.43M | Hold |
1,608,089
| – | – | 0.05% | 62 |
|
|
2023
Q3 | $1.46M | Hold |
1,608,089
| – | – | 0.07% | 61 |
|
|
2023
Q2 | $1.52M | Hold |
1,608,089
| – | – | 0.06% | 67 |
|
|
2023
Q1 | $1.54M | Hold |
1,608,089
| – | – | 0.07% | 69 |
|
|
2022
Q4 | $1.45M | Hold |
1,608,089
| – | – | 0.06% | 62 |
|
|
2022
Q3 | $3.63M | Hold |
1,608,089
| – | – | 0.14% | 61 |
|
|
2022
Q2 | $4.05M | Hold |
1,608,089
| – | – | 0.15% | 60 |
|
|
2022
Q1 | $4.73M | Sell |
1,608,089
-480,000
| -23% | -$1.41M | 0.15% | 62 |
|
|
2021
Q4 | $10.5M | Hold |
2,088,089
| – | – | 0.24% | 59 |
|
|
2021
Q3 | $16.3M | Hold |
2,088,089
| – | – | 0.28% | 59 |
|
|
2021
Q2 | $20.4M | Hold |
2,088,089
| – | – | 0.3% | 64 |
|
|
2021
Q1 | $34.6M | Buy |
+2,088,089
| New | +$34.6M | 0.49% | 55 |
|